Consulting

Consulting & Services

Independent scientific expertise in pharmacokinetics, preclinical drug development, regulatory writing, and pharmaceutical sciences — available for industry, academia, and research organizations.

Approach

Bridging Science and Strategy

With over 12 years of hands-on experience spanning preclinical research, quantitative pharmacology, regulatory submissions, and academic leadership, I offer focused consulting engagements that bring rigorous scientific thinking to your most complex drug development challenges.

Services

Areas of Expertise

01

Pharmacokinetic Analysis & Modeling

Non-compartmental (NCA) and compartmental PK/TK analyses for preclinical studies. Population PK/PD modeling using Phoenix NLME and Monolix. PBPK simulation and human dose prediction with GastroPlus®. Interpretation and reporting of PK parameters for regulatory submissions.

Typical Deliverables

  • NCA / compartmental PK reports
  • Population PK/PD model reports
  • PBPK simulation summaries
  • Human dose prediction memos
02

Preclinical Study Design & Oversight

Strategic design of in vivo pharmacokinetic, toxicokinetic, and efficacy studies. Guidance on species selection, sampling strategy, dose escalation, and study protocol development. Review and critique of CRO-generated study designs and reports.

Typical Deliverables

  • Study protocols and designs
  • Sampling strategy recommendations
  • CRO report review and critique
  • Dose escalation frameworks
03

Regulatory Scientific Writing

Authoring and review of GLP and non-GLP study reports supporting IND, NDA, and BLA submissions. CDISC SEND dataset compliance guidance. Preparation of pharmacology and PK sections for regulatory dossiers. FDA 21 CFR Part 11 data management advisory.

Typical Deliverables

  • GLP / non-GLP study reports
  • IND/NDA/BLA PK sections
  • CDISC SEND compliance review
  • Regulatory strategy memos
04

Formulation Development Advisory

Expert guidance on nanoparticle and conventional dosage form development. Design of Experiments (DoE) strategy for formulation optimization. In vitro dissolution method development for nano drug delivery systems. Physicochemical characterization planning and interpretation.

Typical Deliverables

  • DoE formulation strategy
  • Dissolution method development
  • Characterization protocols
  • Formulation optimization reports
05

Bioanalytical Method Consultation

Guidance on LC-MS/MS and UPLC bioanalytical method development and validation for small molecules and nanoparticle formulations. Review of method validation reports for GLP compliance. Platform selection and data acquisition advisory for Waters Empower and Sciex OS.

Typical Deliverables

  • Method development strategy
  • Validation report review
  • GLP compliance guidance
  • Platform selection advisory
06

Academic & Curriculum Consulting

Development of graduate-level curricula in Pharmaceutics, Biopharmaceutics, Pharmacokinetics, and Drug Regulatory Affairs. SOP and laboratory manual authoring. Research mentorship program design. Peer review and manuscript preparation support for academic researchers.

Typical Deliverables

  • Curriculum frameworks
  • SOP and lab manuals
  • Mentorship program design
  • Manuscript review and editing

How It Works

Engagement Process

1

Initial Consultation

A focused conversation to understand your project scope, timeline, and scientific objectives.

2

Proposal & Scope

A clear written proposal outlining deliverables, timeline, and engagement terms.

3

Active Engagement

Hands-on scientific work with regular progress updates and open communication throughout.

4

Delivery & Review

Final deliverables with a review period to ensure they fully meet your scientific and regulatory needs.

Let's Work Together

Whether you are seeking a research collaborator, a pharmacokinetics consultant, or an independent scientific expert — I welcome substantive conversations about meaningful work.

Get in Touch